Drug: TYKERB Injury: Malignant neoplasm progression Quarter: 2016Q3
Total Records: 4 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
124560355 | TYKERB | Malignant neoplasm progression | NOVARTIS | 0.00 | F | 0 | 20160916 | US |
125827131 | TYKERB | Malignant neoplasm progression | NOVARTIS | 77.00 YR | F | 0 | 20160722 | US |
126587301 | TYKERB | Malignant neoplasm progression | NOVARTIS | 0.00 | F | 0 | 20160817 | US |
127558971 | TYKERB | Malignant neoplasm progression | NOVARTIS | 55.00 YR | F | 0 | 20160916 | BR |
Total Records: 4 Number of Pages: 1